Inventor · disambiguated record
James E. Tarver
Also filed as: TARVER JAMES E · TARVER JR JAMES · TARVER JR JAMES E
6 granted patents·4 pending applications·25 citations·filing 2006–2014
79Inventor score
Top patents by PatentIndex Score
10 records- 0185US8093245B24-amino-1H-pyrimidin-2-one based compounds, compositions comprising them and methods of their useAUGERI DAVID J·Filed 2007·Granted Jan 10, 2012·6 cites·17 claims
- 0284US7825142B2Heterocyclic compounds, compositions comprising them and methods of their useLEXICON PHARMACEUTICALS INC·Filed 2009·Granted Nov 2, 2010·6 cites·10 claims
- 0384US7598280B2Heterocyclic compounds, compositions comprising them and methods of their useLEXICON PHARMACEUTICALS INC·Filed 2008·Granted Oct 6, 2009·6 cites·2 claims
- 0477US8153804B2Aryl pyridines and methods of their useAUGERI DAVID J·Filed 2006·Granted Apr 10, 2012·5 cites·15 claims
- 0574US8093246B2O-linked pyrimidin-4-amine-based compounds, compositions comprising them, and methods of their use to treat cancerAUGERI DAVID J·Filed 2007·Granted Jan 10, 2012·2 cites·18 claims
- 0648US2011082178A1Methods of treating autoimmune and inflammatory diseases and disordersLEXICON PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 0743US9624238B24H-thieno[3,2-C]chromene-based inhibitors of Notum Pectinacetylesterase and methods of their useBARBOSA JOSEPH·Filed 2014·Granted Apr 18, 2017·0 cites·13 claims
- 0842US2014288071A1Inhibitors of notum pectinacetylesterase and methods of their useBARBOSA JOSEPH·Filed 2014·Application pending·0 cites
- 0936US2012302562A14h-thieno[3,2-c]chromene-based inhibitors of notum pectinacetylesterase and methods of their useBARBOSA JOSEPH·Filed 2012·Application pending·0 cites
- 1036US2012065200A1Inhibitors of notum pectinacetylesterase and methods of their useBARBOSA JOSEPH·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when James E. Tarver files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →